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ABSTRACT 
 
Estrogen stimulation of the medial amygdala (MEA) of the brain promotes male rat mating behavior. 
However, selective stimulation of either of the estrogen receptor subtypes found in the MEA (ERα or 
ERβ) does not support mating behavior. We tested the hypothesis that dual stimulation of ERα and ERβ 
is required to activate estrogen-dependant neural circuits in the MEA responsible for mating by local 
treatment of MEA with a combination of selective estrogenic agonists:  propyl pyrazole triol (PPT, an 
ERα agonist ) and diarylpropionitrile (DPN, an ERβ agonist) administered to castrated, DHT maintained 
male rats. Estradiol (E2) or cholesterol (Chol) MEA implants served as positive and negative controls 
respectively. The animals receiving a mixture of PPT and DPN into the MEA displayed higher levels of 
mating behavior than the Chol treated animals but lower levels of mating behavior than the E2 treated 
animals. 
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1. INTRODUCTION 
Testosterone (T) is required for male rat mating behavior to occur. Castrated males show a decline in 
mating behavior [Davidson, 1966a, 1966b] but mating can be restored with administration of exogenous 
T [Christensen and Clemens, 1974; Davidson, 1966a, 1966b]. At least two biologically active T derivatives 
are formed in the male rat brain, the estrogen estradiol (E2) and the androgen dihydrotestosterone 
(DHT). E2 is produced from T by aromatase [Naftolin et al., 1975], whereas DHT is produced by the 
conversion of T to DHT by 5α reductase [Martini, 1982; Massa et al., 1972]. Alone, neither E2 [Baum and 
Vreeburg, 1973; Davidson, 1969] nor DHT [Davidson, 1966a; Feder, 1971; McGinnis and Dreifuss, 1989] 
are as effective as T in their ability to fully maintain mating. Nevertheless, combined treatment with 
physiological doses of  E2 and DHT restores mating behavior to levels comparable to T-treated animals 
[Baum and Vreeburg, 1973], suggesting that both androgenic and estrogenic derivatives of T jointly play 
a role in expression of copulatory behavior by male rats.  
Fadrozole (Fad), a non-steroidal aromatase inhibitor, blocks the conversion of T into E2 [Bonsall 
et al., 1992; Lipton et al., 1990]. Systemic administration of Fad and T to castrated male rats significantly 
reduces mating behavior compared to rats treated with water and T [Bonsall et al., 1992]; reinforcing 
the important role that E2 plays in mating behavior. When  gonadally intact male rats are treated with 
Fad infusions directly into the MEA, the animals displayed significantly fewer intromissions and 
ejaculations with significant increases in mount and intromission latencies and the post ejaculatory 
interval in comparison to  controls that receive saline infusions into the MEA [Huddleston et al., 2006], 
suggesting that estrogen is required in MEA to support mating.  Mounts and intromission, but not 
ejaculations, were maintained at levels not significantly different from preoperative values in gonadally 
intact male rats treated with Fad systemically and bilateral E2 implants in the MEA. In contrast, mounts, 
intromissions, and ejaculations declined significantly in gonadally intact rats receiving systemic Fad and 
blank MEA cannulae [Huddleston et al., 2003]. The combined results of these experiments indicate that 
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aromatization of T into E2 in the MEA is critical for expression of mounting and intromission and that E2 
contributes to activation of neural circuits in MEA presumed to be involved in the motivation of mating 
behavior.  
For estrogen to have a physiological effect, it must bind to estrogen receptors (ER) in its target 
cells. Two types of ERs are well known and studied: estrogen receptor alpha (ERα) and estrogen 
receptor beta (ERβ) [Koike et al., 1987; Kuiper et al., 1996; Mosselman et al., 1996]. The two receptors 
are coded by different genes and exhibit a high degree of similarity in their ligand (E, 58%) and DNA 
binding domains (C, 96%) whereas other domains, A, B, D, and F, are poorly conserved [Mosselman et 
al., 1996]. Both receptors bind with high affinity to steroidal estrogens but vary in their ability to bind to 
nonsteroidal ligands [Charn et al., 2010; Lindberg et al., 2003; Paulmurugan et al., 2011]. A smaller ERβ 
ligand binding cavity [Hillisch, 2004] may account for this difference and prove to be useful 
experimentally when trying to selectively activate one of the receptors while being assured that the 
other subtype remains inactive. It is known that estrogen receptors undergo dimerization and may form 
homodimers or heterodimers [Cowley et al., 1997]. The similarity in the C domain, a domain responsible 
for DNA binding and dimerization of receptors, may account for the ability of ERα and ERβ to form 
heterodimers. Heterodimer formation is possible in cells where both ER subtypes colocalize. Findings 
reported by several laboratories indicate that ERα and ERβ are co-expressed in MEA [Greco et al., 2001; 
Greco et al., 2003; Mitra et al., 2003; Shughrue et al., 1997; Shughrue et al., 1998]. Furthermore, in 
female rat’s  dorsal portion of posteriodorsal MEA (MEApd) both ERα and ERβ containing cells are 
activated by mating and  express mating-induced Fos-ir, a marker of neuron activity, whereas,  in the 
ventral portion of MEApd, only ERβ cells are Fos expressive [Greco et al., 2003].  This highlights the 
importance of both ER receptor subtypes in the MEA in the expression of mating behavior.  
When an ERα antisense oligodeoxynucleotide (AS-ODN) complementary to the mRNA of ERα 
was  infused locally into MEA, ERα expression  was inhibited in the MEA but this did not significantly 
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reduce mating behavior in gonadally intact male rats [Paisley et al., 2012]. Conversely, AS-ODN infusion 
of the medial preoptic area (MPO) significantly reduced copulation, which suggests that the sexual 
response of the MPO to estrogen is mediated by ERα to a greater degree than the response to estrogen 
of the MEA [Paisley et al., 2012]. Moreover, neither MEA implants of propyl pyrazole triol (PPT [Stauffer 
et al., 2000]), an ERα agonist, nor diarylpropionitrile (DPN [Meyers et al., 2001]), an ERβ agonist, 
maintained mating in castrated male rats administered DHT s.c. whereas E2 MEA implants were effective 
[Russell et al., 2012]. Taken together, it appears that estrogen may not act through a single ER pathway 
in MEA because ERα alone is not necessary and ERβ alone is not sufficient to promote the sexual 
response of MEA to estrogen. However, because estrogen is required in MEA, it is possible that ERα and 
ERβ normally work together to mediate the sexual response of MEA to estrogen. Therefore, we 
hypothesized that, in MEA, both ERα and ERβ must be simultaneously activated in order to promote 
expression of mating behavior.  
To test this hypothesis we examined the effects of combined implantation of the selective non-
steroidal estrogenic ERα and ERβ agonistic drugs, PPT and DPN respectively, locally into the MEA on 
mating behavior of castrated DHT s.c. maintained male rats. As a positive control, E2 was implanted into 
MEA, and as a negative control, cholesterol (Chol) was implanted into MEA.  We expected that animals 
receiving a mixture of ERα and ERβ agonists would show high levels of mating behavior comparable to 
animals receiving E2, whereas Chol MEA implants would not maintain mating.  
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2. MATERIALS AND METHODS 
2.1. Animals 
Male and female Sprague Dawley rats obtained from Charles River Laboratories were housed in 
polycarbonate cages, 22 x 44 x 18 cm, with free access to food and water in the Georgia State University 
vivarium. Male rats were housed two per cage until surgery; post-operatively, male rats were housed in 
individual cages. Female rats were housed two per cage throughout the experiment except during post-
operative recovery. The animals were kept in a climate controlled rat colony on a reversed 14:10 hour 
reverse light: dark cycle (lights off at 0930 hours EST). Animal care and surgical procedures were in 
accordance with the Georgia State University IACUC and the NIH Guide for the Care and Use of 
Laboratory Animals (NIH Publ. No. 85-23, revised 1985). 
2.2. Female rat surgical procedures 
Female rats  were anesthetized with isoflurane (5% gas at 1.0 LPM oxygen exchange rate to 
induce and 2-3% gas at 0.3 LPM oxygen to maintain), ovariectomized through a midline abdominal 
incision and implanted s.c. in the scapular region with a 6 mm Silastic crystalline E2-filled capsules. 
Postoperatively, the female rats received intramuscular injections of Penicillin (0.1 ml in benzathine 
penicillin G+ procaine penicillin G) and carprofen (5 mg/kg) to reduce the possibility of infection and to 
alleviate pain during recovery. The females were given at least 7 days to recover before the initiation of 
weekly sexual behavioral tests.  On behavioral test days, female rats received s.c. an injection of 
progesterone (1 mg progesterone in 0.2 ml of sesame oil) at least 4-6 hours prior to being paired with 
males to render them sexually receptive.  
2.3 Sexual behavior screening 
Male rats were screened for the display of sexual behavior in weekly 30 minute mating tests 
over a 4 week period. The tests were performed under a red light illumination during the dark phase of 
the light: dark cycle. During the test each male was placed with a sexually receptive female in a 22 x 44 x 
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50 cm polycarbonate cage for a 30 minute period. The recorded data included: mount frequency (MF)- 
number of mounts without penetration; intromission frequency (IF) – number of mounts with 
penetration;  ejaculation frequency (EF) – number of ejaculations; mount latency (MLAT)- time passed 
from the start of the test until the first mount or intromission; ejaculation latency (ELAT)- time passed 
from the first mount or intromission until the first ejaculation; post-ejaculatory interval (PEI) – time from 
the first ejaculation to the subsequent mount or intromission. The data were recorded by testers blind 
to the experimental status of the animals in order to minimize experimenter bias. Based on the obtained 
ejaculatory frequencies the animals were assigned into 3 matched groups, those receiving: 1) estradiol 
to the MEA (E2 group), the positive control, 2) cholesterol to the MEA (Chol group), the negative control 
and 3) a 50%/50% wt/wt (50/50) mixture of PPT and DPN to the MEA (PD group).  
2.4. Cannulae Implantation, Castration and Postoperative Screening 
The male rats were anesthetized with isoflurane as described above and the testes were 
removed through an abdominal incision. The animals received a 10 mm Silastic capsule filled with DHT 
s.c. in the scapular region. DHT capsules of this size have been reported to produce physiological levels 
of circulating DHT [Ando et al., 1998; Lugg et al., 1995; Parte and Juneja, 1992]. While still deeply 
anesthetized, the male rats were then placed into a stereotaxic instrument and implanted intracranially 
with bilateral 22-gauge stainless steel, ethylene oxide sterilized guide cannulae aimed at the MEA (level 
skull coordinates: AP=-3.2 mm, ML=3.5 mm, DV=-8.2 mm [Swanson, 1998]. 28-gauge stainless steel, 
ethylene oxide sterilized inner cannulae filled with the appropriate drug, either a 50/50 mixture of PPT 
and DPN, or E2, or Chol, were inserted extending 1 mm below the guide cannulae. Postoperatively, the 
male rats received intramuscular injections of Penicillin (0.1 ml in benzathine penicillin G+ procaine 
penicillin G) and carprofen (5 mg/kg) to reduce the possibility of infection and to alleviate pain during 
recovery.  The males were given at least 7 days to recover prior to the onset of post-operative 
behavioral testing. The inner cannulae were replaced with fresh, drug filled and ethylene oxide sterilized 
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cannulae two days prior and one day following a behavior test to ensure that the MEA was chronically 
exposed to the appropriate drug. Microscopic inspection of the cannulae tips removed from the 
experimental animals showed that the drug was present at the cannulae tips at least 98% of the time. 
The animals were behaviorally tested for 30 minutes each week as described above for 7 consecutive 
weeks.  
2.5. Histological Analysis 
After the testing period was terminated, the male rats were euthanized with an overdose of 
sodium pentobarbital (100 mg/kg i.p.) and perfused transcardially for 5min with physiological saline 
followed by a minimum of 300 ml of 4% paraformaldehyde in 0.1 M phosphate buffer (PB) solution (pH 
7.4). The skulls were partially opened and stored in the perfusion fixative overnight. The following day, 
the brains were dissected and stored in a solution of 30% sucrose in 0.1 M PB for at least 48 hrs. Frozen 
coronal brain sections (40 µm) through the amygdala were collected in 0.1 M PB, mounted on gel-
albumin coated slides, and stained with toluene blue to microscopically verify cannulae placement.  
2.6. Statistical Analysis  
Kruskal–Wallis one-way analysis of variance was used to determine if there was a significant in-
between group difference during the terminal pre-operative, first post-operative, and terminal post-
operative tests [Siegel, 1956]. If the results showed a significant group difference, pairwise Mann–
Whitney U tests were used to determine the origin of the group difference by comparing E2 to Chol, E2 
to PD, and PD to Chol groups. Wilcoxon signed-rank test was used to determine within group differences 
between the data values obtained during terminal pre-operative and terminal post-operative tests 
[Siegel, 1956]. Fisher’s test was used to compare the proportions of animals that mated in each group 
during the terminal post-operative test [Siegel, 1956].  
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3. RESULTS 
The three groups showed robust mating during the pre-operative period and on the third pre-
operative test (terminal pre-operative test) there were no significant group differences in any of the 
behavioral indices. Mating behavior diverged significantly between groups during the post-operative 
period. Specifically, castrated, DHT maintained male rats receiving Chol implants to the MEA showed a 
significant, progressive decline in all indices between the terminal pre-operative test and seventh post-
operative test (terminal post-operative test).  Conversely, except for an initial significant decline in all 
mating indices on the first post-operative test, E2- MEA implanted rats continued mating such that, on 
most behavioral indices by the terminal post-operative test, these animals mated at levels not 
significantly different from those during the terminal pre-operative test. All behavioral indices of the PD 
group declined significantly between the last pre-operative test and 1
st
 post-operative test but were 
stably maintained at this lower level throughout the post-operative period and were intermediate 
between the Chol and E2 groups. The proportion of male rats in the PD group that mounted or 
intromitted during the terminal post-operative tests did not differ significantly from the proportion of 
male rats in the E2 group that mounted or intromitted during the terminal post-operative test. 
Conversely, the proportion of animals receiving Chol-MEA implants mounted or intermitted at rates that 
were significantly lower than those in both the PD and E2 groups.  
Although the three groups did not differ significantly from each other in MF during the terminal 
pre-operative trial, all 3 groups showed a significant decline in MF on the first post-operative trial (Chol 
p<0.025; E2 p<0.029; PD p<0.001) but did not differ significantly from each other. By the terminal post-
operative test, however, the MF displayed by the E2 group returned to levels that were not significantly 
different from terminal pre-operative values. Conversely, the Chol group showed a steady decline in MF 
and by the terminal post-operative test, the frequency of mounts performed by the animals in this 
group was significantly lower compared to the values obtained during the terminal pre-operative and 
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first post-operative trials (p<0.003 and p<0.005 respectively). In the PD group, after an initial significant 
drop in MF between the terminal pre-operative and the first post-operative tests, MF was maintained at 
a steady rate during the post-operative trials such that the MF was not significantly different between 
the first and the terminal post-operative tests. However, MF was significantly lower (p<0.005) on the 
terminal post-operative test than on the terminal pre-operative test. Between-group pairwise 
comparison conducted on the terminal post-operative tests showed that rats in E2 group mounted at 
significantly higher frequencies of than rats in both PD and Chol groups (p< 0.040; p<0.003 respectively), 
although MF measures for the PD group were numerically, but not significantly, higher than those of the 
Chol group.  A similar pattern was seen for MIF (mount and intromission frequency) in all of the groups. 
Between-group pairwise comparison of MIF performed by male rats during the terminal post-operative 
trial showed that MIF rates were significantly higher in E2 group than in Chol group (p<0.003) but MIF 
was not significantly different in the PD group compared to the E2 group, nor was the PD group 
significantly different compared to the Chol group (Figure 1A, 1C).   
 The three groups were not significantly different in the number of Intromissions during the 
terminal pre-operative trial. Immediately after the surgery, on the first post-operative test, IF in each of 
the groups decreased significantly (Chol p<0.003; E2 p<0.009; PD p<0.001) compared to the terminal 
pre-operative trial. Thereafter, however, the IF was maintained at a steady level in the E2 and PD groups 
so that by terminal post-operative test the IF was not significantly different from the values obtained 
during the first post-operative test for each group. However, in both the E2 and PD groups these values 
were significantly lower than those on the terminal pre-operative trial (E2 p<0.009; PD p<0.001). The 
Chol group showed a progressive decline in IF throughout the post-operative trials such that the values 
obtained during the terminal post-operative trial were significantly lower compared to both terminal 
pre-operative and first post-operative trials (p< 0.003; p<0.005 respectively). Between-group pairwise 
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comparison showed that three groups did not differ from each other in IF during the terminal post-
operative trial (Figure 1B).  
 There were no significant between-group differences in ejaculation frequency (EF) on the 
terminal pre-operative trial. During the first post-operative trial the values for EF declined in all of the 
groups; although, only the Chol and PD groups show a significant reduction in EF compared to the 
terminal pre-operative trial (p<0.044; p<0.007 respectively). EF continued to decline in each of the three 
groups throughout the post-operative trials and were significantly lower by the terminal post-operative 
test compared to terminal pre-operative test (Chol p<0.005; E2 p<0.012; PD p<0.002). However, on the 
terminal post-operative trial EF displayed by male rats in the E2 and PD groups did not differ significantly 
in comparison to EF seen during the first post-operative trial. On the other hand, Chol group ejaculated 
significantly fewer times on the terminal postoperative test compared to first post-operative test 
(p<0.018). Pairwise between- group comparison of EF observed during the terminal post-operative trial 
showed no significant differences in ejaculatory rates between the three groups (Figure 1D).  
 During the terminal pre-operative trial, there were no significant differences between the three 
groups in any of the latency measures, MLAT, ELAT, and PEI. In-between and within-group differences 
developed after the male rats were castrated and received a DHT s.c. capsule and an implant of Chol, E2, 
or PPT and DPN into the MEA. Overall, Chol group displayed highest latency measures while E2 group 
had the shortest latency measures and the PD group values were intermediate between the two other 
groups. Post-operatively, MLAT increased numerically in all three groups, but the elevation between the 
last pre-operative and the first post-operative tests was only significant in the PD group (p<0.008). MLAT 
of the male rats in the Chol group continued to rise throughout the post-operative testing period and by 
the terminal post-operative trial was significantly higher than during the terminal pre-operative and the 
first post-operative trials (p<0.003; p<0.005 respectively). MLAT of the E2 group remained slightly 
elevated numerically throughout the post-operative period compared to the terminal pre-operative 
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trial, but was not significant. The male rats that received PD-MEA implants displayed significantly longer 
MLAT during the terminal post-operative test when compared to the terminal pre-operative values 
(p<0.006), but these values were not significantly different from those on the first post-operative test. 
Between-group pairwise comparison of MLAT observed during the terminal post-operative trial revealed 
that in the Chol group MLAT was significantly higher than that of E2 group (p<0.003) but no other 
significant differences in MLAT occurred  between the Chol and PD or E2 and PD groups (Figure 2A). 
Post-operatively, a similar trend was observed in ELAT as with MLAT (Figure 2B). During the first post-
operative test, all of the groups showed a significant elevation of PEI compared to the terminal pre-
operative trial (Chol p<0.026; E2 p<0.006; PD p<0.001). During the terminal post-operative trial, the PEI 
measure in the  Chol group was significantly longer from the measures obtained during the terminal pre-
operative and first post-operative tests (p< 0.005; p<0.017 respectively). The lowest PEI measure 
occurred in the E2 group and the PEI of PD group was intermediate compared to E2 and Chol groups. 
Specifically, in both, the E2 and the PD, groups the PEI was significantly longer during the terminal post-
operative test when compared to the terminal pre-operative test (p<0.004; p<0.001 respectively) but 
were not significantly different from the values obtained during the first post-operative test. Between-
group pairwise comparison of PEI observed during the terminal post-operative trial showed no 
significant differences between the three groups (Figure 1C).  
The proportions of animals that mounted or intromitted during the terminal post-operative test in the E2 
(9 of 11) or PD (7 of 14) groups were significantly greater than the proportions of animals that that 
mounted or intromitted in the Chol group (1 of 11) (p<0.002, p<0.042 respectively).  Moreover, the 
proportions of the animals in the E2 group that mounted or intromitted on the terminal post-operative 
trial did not differ significantly from that in the PD group (Figure 3A). The proportion of animals that 
ejaculated during the terminal post-operative test was highest in the E2 group (5 of 11) and lowest in the 
Chol group (1 of 11); the PD group values (4 of 14) were intermediate between the other two groups. 
  
11 
These values did not differ significantly between the three groups (Figure 3B). The histological analysis 
showed that the cannulae were located in or near the MEA in all three groups (Figure 4).  
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Time course of E2 (n=11), PPT and DPN (n=14) , and Chol (n=11) effects on mating frequencies of 
castrated, DHT maintained male rats. The three groups were not significantly different during the pre-
operative trials. The differences in behavioral indices arose post-operatively. A: Mount Frequency. Post-
operatively, all 3 groups showed a significant decline in MF between the last pre-operative and the first 
post-operative tests. MF returned to values not different from  those obtained during the pre-operative 
trials in the E2-MEA group. Animals in the Chol-MEA group showed a steady decline in MF. Male rats 
that received PD-MEA implants were intemediate. B: Intromission Frequency. Post-operatively, all 3 
groups showed a significant decline in IF between the last pre-operative and the first post-operative 
tests. IF did not return to pre-operative lvels in any of the groups. C: Mount and Intromission 
Frequency. MIF follows the same pattern as MF. D: Ejaculation Frequency. Post-operatively, all 3 groups 
showed a significant decline in EF compared to pre-operative levels. EF continued to decrese throughout 
the post-operative trials so that by the terminal post-operative test all the groups showed siglificantly 
lower EF compared to terminal pre-operative test and the groups did not differ significantly from each 
other.  
* Within-group difference during the terminal pre-oprerative test and first post-operative test, p<0.05. 
+ Within-group difference during the terminal pre-oprerative test and terminal post-operative test, 
p<0.05. 
# Within-group difference during the first post-operative test and terminal post-operative test, p<0.05. 
E/C- Group difference between Estradiol and Cholesterol, p<0.05.  
PD/E- Group difference between PPT+DPN and Estradiol, p<0.05.  
PD/C- Group difference between PPT+DPN and Cholesterol, p<0.05. 
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FIGURE 2: MALE SEXUAL BEHAVIORAL LATENCIES.   
  
15 
Time course of E2 (n=11), PPT and DPN (n=14) , and Chol (n=11) effects on mating latencies of castrated, 
DHT maintained male rats. The three groups were not significantly different during the pre-operative 
trials. The differences in behavioral indices arose post-operatively.A: Mount Latency. During the first 
post-operative test, MLAT increased for  all of the groups, however, only in the PD group was this 
significant. Throughut the post-operative trials MLAT continued to rise for all of the groups numerically. 
During the terminal post-operative trial E2-MEA displayed the lowest MLAT values that were 
numerically but not significantly higher compared to the pre-operative values. PD-MEA and Chol-MEA 
groups showed significantly higher MLAT than on the terminal post-operative test compared to the 
terminal pre-operative values. These two groups were not significantly different from each other, yet 
numerically Chol-MEA group displayed longer MLAT than the PD-MEA group. B: Ejaculation Latency. 
ELAT MIF followed the same trend as MLAT. C: Post Ejaculatory Interval. Each group showed a 
significant elevation of PEI on the first post-operative trial. The values for PEI continued to rise 
throughout the post-operativetests and were significantly higer for all of the groups on the terminal 
post-operative test.  
 
* Within-group difference during the terminal pre-oprerative test and first post-operative test, p<0.05. 
+ Within-group difference during the terminal pre-oprerative test and terminal post-operative test, 
p<0.05. 
# Within-group difference during the first post-operative test and terminal post-operative test, p<0.05. 
E/C- Group difference between Estradiol and Cholesterol, p<0.05.  
PD/E- Group difference between PPT+DPN and Estradiol, p<0.05.  
PD/C- Group difference between PPT+DPN and Cholesterol, p<0.05. 
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FIGURE 3: MALE SEXUAL BEHAVIOR.  
  
17 
Terminal post-operative mating behaviors (percentages) for the E2, PD, and Chol groups. A: Percent 
Intromitted or Mounted. A large proportion (9 of 11, 81.8%) of castrated DHT maintained  male rats 
given E2-MEA implaints mounted and intromitted and the proportion of rats receiving PD-MEA implants 
that mounted and intromitted (7 of 14, 50.0%)  did not differ significantly from the E2-MEA group. Only 1 
out of 11 (9.09%) castrated male rats receiving Chol-MEA implants mounted and intromitted and the 
MIF proportion for this group was significantly lower than either the E2 or PD  group. B: Percent 
Ejaculated. None of the groups were significantly different from each other.  
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FIGURE 4: CANNULAE PLACEMENT TO THE MEA. 
 Location of the cannulae tips of male rats implanted with Chol, E2, or PPT and DPN into the MEA. 
Cannulae tips were positioned in or near the MEA in all groups. The black dots represent cannula tip 
locations.  
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4. DISCUSSION 
Because, in the MPO, mating behavior is supported by activation of a single receptor (ERα), [Russell et 
al., 2012] it was expected that the estrogen-sensitive neural circuits of MEA might work similarly. 
However, this is not the case. Stimulation of MEA ERα alone by PPT (ERα agonist) did not mimic the 
actions of E2 and did not support mating behavior [Russell et al., 2012]. Moreover, stimulation of MEA 
ERβ by DPN (ERβ agonist) alone also does not promote mating [Russell et al., 2012]. Therefore, because 
in the MEA the effect of either PPT or DPN is more limited and selective than that of E2, the objective of 
this experiment was to determine if simultaneous stimulation of both ER subtypes is required for 
activation of the estrogen-sensitive neural circuits within MEA that mediate mating behavior.  
 The hypothesis was confirmed by examining the mating response of male rats implanted with a 
combination of selective estrogenic agonists of ERα and ERβ (PPT and DPN respectively) into the MEA 
and by comparison of this group to controls receiving E2 or Chol MEA implants. Because only MEA and 
not other brain areas important for mechanical execution of copulatory behavior, such as MPO, were 
stimulated, we expected post-operative behavioral indices to be lower for all of the groups; we also 
expected that only mounts and intromissions, but not ejaculations, would be maintained [Huggleston 
et.al., 2003]. Therefore, ejaculation frequency, ejaculation latency, and post ejaculatory interval did not 
figure prominently in the evaluation of the data although these data are included in the results.  
During the pre-operative trials animals in all groups (PD, E2, and Chol) mated vigorously and 
were not significantly different from each other on any behavioral indices. The number of mounts and 
intromissions declined significantly in all groups post-operatively as expected. Mounts and intromissions 
displayed by the E2-MEA group returned to the pre-operative levels by the terminal post-operative trial, 
while the mounts and intromissions displayed by  animals receiving Chol-MEA implants declined 
progressively throughout the postoperative period and were significantly lower on the terminal post-
operative week compared to the terminal pre-operative and first post-operative trials. Although PD-
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MEA implants failed to maintain mounts and intromissions at the pre-operative levels they did maintain 
these mating behavior indices at the levels not significantly different from those seen during the first 
pre-operative trial. Between-group statistical comparison of the mounts and intromissions exhibited by 
the rats in the three groups on the terminal post-operative week showed that PD group was not 
significantly different from the E2 group, nor was it significantly different from the Chol group. 
Furthermore, on the terminal post-operative trial the proportions of animals that displayed mounts or 
intromissions in the PD-MEA and E2-MEA groups were significantly higher than the proportion of animals 
displaying mounts or intromissions in the Chol-MEA group and the PD-MEA group did not differ 
significantly from the E2-MEA group. These findings suggest that MEA responded to activation by 
combined administration of ERα and ERβ selective estrogenic agonists, however, the response did not 
precisely mimic that of E2. Nevertheless, we conclude that ERα and ERβ play a role in activation of 
estrogen sensitive circuits in MEA responsible for mediation of mating behavior because combined 
application of PPT and DPN produced results that were numerically and in some instances significantly 
higher than those observed in Chol treated animals while singular application of either of the drugs did 
not produce these effects [Russell et al., 2012].  
Although activation of MEA through simultaneous administration of PPT and DPN was 
successful, dual administration of these ER agonists did not mimic the action of E2 in the MEA. The 
plausible explanations for this may lie in the dosage of drugs administered. The animals in the PD group 
were given a 50/50 mixture of PPT and DPN because an appropriate ratio of PPT/DPN required to 
activate E2-dependent circuits in the MEA is not known. Perhaps, if the ratio of the drugs had been 
altered, we would have observed the rats displaying mating behavior at the levels not statistically 
different from rats receiving E2-MEA treatment. When ERα expression was knocked out or knocked 
down in MEA, the mating was not affected [Paisley et al., 2012]. This previous finding, together with the 
results of this experiment, raise the possibility that ERα plays a secondary role in the MEA and is 
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required in lower concentrations than ERβ. Thus, a 50/50 mixture of PPT and DPN might not have 
provided enough of ERβ agonist to full activate the circuits in MEA. 
Although our findings provide some information about the role of E2 in MEA to promote mating 
behavior, the mechanisms of E2 action is MEA are still not well understood. Several studies showed that 
ERα and ERβ are co-expressed in cells of MEA and that in female rats the cells that co-express both 
receptor subtypes also exhibit FOS-ir in response to mating stimuli [Greco et al., 2003; Shughrue et al., 
1997; Shughrue et al., 1998]. It is also known that ERα and ERβ undergo dimerization to form 
homodimers and heterodimers during the reaction cascade that results in gene activation leading to 
expression of mating behavior [Cowley et al., 1997]. ERs are able to form heterodimers if both receptor 
subtypes are colocalized within a cell and it has been proposed that different functions are rendered 
based on the type of dimer that could be formed in an area [Shughrue et al., 1997; Shughrue et al., 
1998]. However, a new finding showed that heterodimers may be formed when only one subtype is 
bound by a ligand [Paulmurugan et al., 2011]. Therefore, when PPT alone was given, it is possible that 
ERα/ERβ heterodimer was formed along with an ERα homodimer and when DPN was given alone, it is 
possible that ERα/ERβ heterodimer was formed along with an ERβ homodimer. Neither of these pairs of 
dimers were sufficient to activate E2-dependent neuronal circuits in MEA [Russell, et al., 2012]. 
However, when a combination of PPT and DPN was administered to MEA, it is possible that ERα/ERβ 
heterodimer, an ERα/ERα and an ERβ/ERβ homodimers were also formed and that all three dimers are 
required to facilitate mating behavior.   
The results of this experiment might appear to contradict previous findings because it was 
shown that, in the MEA, ERα is not necessary for male rats to display mating behavior [Paisley et al., 
2012]. However, the current findings suggest that ERα nevertheless participates in the signaling pathway 
which leads to the display of mating behavior by male rats. There are multiple plausible explanations for 
these apparently conflicting findings. It is possible that ERβ is required in MEA but cannot promote 
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mating behavior on its own and instead must be coupled to another receptor in order to generate the 
response. Although ERβ might normally be coupled to ERα, there might be other possibilities. Because 
mating behavior persists when ERα mRNA expression is inhibited [Paisley et al., 2012], it is possible that 
ERβ may couple to another non-ERα receptor (not yet identified).  Another possibility could involve two 
different pathways, one of which engages dimers of ERα and ERβ, while the other proceeds through a 
novel type of E2 receptor not linked to ERα or ERβ. Yet another interpretation may emerge from this 
experiment. It is reasonable to assume that when expression of ERα mRNA was inhibited in MEA by AS-
ODN infusion [Paisley, et al., 2012], it did not completely knock out ERα, but rather only knocked down 
ERα expression. The reduced level of ERα in MPO may have been too low to support the mating 
behavior if ERα is primarily responsible for E2 actions in MPO [Paisley et al., 2012; Russell et al., 2012]. 
However, low residual levels of ERα in MEA might still be enough to sustain the response of the MEA to 
E2 because they may aid ERβ even if ERα is not the primary E2 receptor of MEA.  To further investigate 
the actions of E2 in MEA an anatomical study of male MEA to test if the cells co-expressing ERα and ERβ 
also would exhibit Fos-ir upon mating stimulation might be valuable. Nevertheless, it  now appears that 
E2 dependent circuits in the MEA responsible for activation of mating behavior in male rats proceed 
through simultaneous activation of both ERα or ERβ and that both receptor subtypes are important in 
the MEA.  
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